Skip to main content

Table 2 Individual patient profiles of baseline characteristics

From: Cybernic treatment with wearable cyborg Hybrid Assistive Limb (HAL) improves ambulatory function in patients with slowly progressive rare neuromuscular diseases: a multicentre, randomised, controlled crossover trial for efficacy and safety (NCY-3001)

Targeted neuromuscular diseases Patient ID Group Age
(years)
Barthel Index
(0–100)
2MWT
(m)
Total MMT scores
(0–60)
Spinal muscular atrophy 1-3 A 52 95 116.3 35
6-1* A 48 100 97.3 37
6-2* A 57 90 66.5 30
1-1 B 59 85 39.3 33
9-6 B 57 60 68.6 28
Spinal bulbar muscular atrophy 1-2 A 64 80 41.9 36
5-1* A 54 60 30.1 39
Amyotrophic lateral sclerosis 3-2 A 69 25 30.3 26
Charcot Marie Tooth disease 9-3 A 76 95 120.1 39
8-1 B 55 95 55.3 31
8-2 B 63 85 126.5 37
Myotonic dystrophy 9-2 B 65 90 75.3 32
9-4 B 51 90 90.4 28
Distal myopathy with RV 2-3* B 40 100 87.7 24
Distal myopathy, Myoshi 2-4* A 50 80 78.3 23
5-3* A 63 65 25.0 31
2-2 B 58 90 85.2 30
7-2* B 47 85 59.7 36
FSH-type muscular dystrophy 1-4* A 40 90 56.8 37
2-7 A 46 75 57.3 29
2-6 B 51 85 79.1 31
Other limb girdle-type muscular dystrophy 2-5* A 33 55 97.1 26
9-7 B 65 65 48.3 29
Sporadic inclusion body myositis 3-1* A 76 65 61.7 34
  1. The patient ID indicates site number-patient number. An asterisk (*) in a patient’s ID indicates the outpatient status during the study period